Uveitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are a man or woman aged 18 to 70 years old and are generally in good health
- You have inflammation inside one or both eyes (a condition called uveitis) that affects the back part of the eye and is not caused by an infection
- You have signs of active eye inflammation before receiving the Yutiq treatment, shown by at least one of the following: significant cell activity or cloudiness in the eye, leakage seen on a special eye imaging test, swelling at the centre of your vision seen on a scan, or three or more flare-ups of your condition in the past year
- You are willing to stop taking steroids and immune-suppressing medications within 3 months after receiving the Yutiq injection
Who may not be able to join:
- You have cloudiness in the cornea or lens that blocks a clear view of the back of your eye, or you are likely to need cataract surgery during the trial
- You have a history of neurological symptoms that suggest a nerve-related condition affecting the brain or spinal cord
- You have received certain long-acting eye implants or injections (Retisert®, ILUVIEN®, or YUTIQ®) in the last 36 months
- You have received a specific steroid eye injection called OZURDEX®, Triesence®, or TRIVARIS™ in the last 12 weeks
- You have had a steroid injection around or near your eye in the last 12 weeks
- You have cloudiness inside your eye (for example, bleeding in the eye) that prevents a clear view of the retina
- You have a known allergy to any ingredient in YUTIQ®
- You have any other eye or general health condition that the trial doctor believes would make it unsafe or unsuitable for you to take part (confirm with trial site)
- You are pregnant or breastfeeding, or you are a woman who could become pregnant and are unwilling or unable to use an approved method of contraception from at least 14 days before the trial starts until the final visit
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +8613920023990
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change In LogMAR Best Corrected Visual Acuity (BCVA) From Baseline to Each Visit.; Recurrence rates
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.